ATE310515T1 - Verbesserte krebsbehandlung mit temozolomid - Google Patents

Verbesserte krebsbehandlung mit temozolomid

Info

Publication number: ATE310515T1
Authority: AT; Austria
Prior art keywords: temozolomide; cancer treatment; improved cancer; improved; treatment
Prior art date: 1999-03-30

Application number

AT00918435T

Other languages

English (en)

Inventor

Mohamed H Ragab

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-30

Filing date

2000-03-27

Publication date

2005-12-15

2000-03-27 Application filed by Schering Corp filed Critical Schering Corp

2005-12-15 Application granted granted Critical

2005-12-15 Publication of ATE310515T1 publication Critical patent/ATE310515T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT00918435T 1999-03-30 2000-03-27 Verbesserte krebsbehandlung mit temozolomid ATE310515T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28134899A	1999-03-30	1999-03-30
PCT/US2000/008079 WO2000057867A2 (en)	1999-03-30	2000-03-27	Improved cancer treatment with temozolomide

Publications (1)

Publication Number	Publication Date
ATE310515T1 true ATE310515T1 (de)	2005-12-15

Family

ID=23076905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00918435T ATE310515T1 (de)	1999-03-30	2000-03-27	Verbesserte krebsbehandlung mit temozolomid

Country Status (18)

Country	Link
EP (1)	EP1165071B1 (de)
JP (2)	JP2002540148A (de)
CN (2)	CN1345240A (de)
AR (1)	AR023185A1 (de)
AT (1)	ATE310515T1 (de)
AU (1)	AU780892B2 (de)
BR (1)	BR0009380A (de)
CA (1)	CA2368614C (de)
DE (1)	DE60024243T2 (de)
DK (1)	DK1165071T3 (de)
ES (1)	ES2251987T3 (de)
HK (1)	HK1044111B (de)
HU (1)	HUP0200805A3 (de)
NO (1)	NO330651B1 (de)
NZ (1)	NZ536302A (de)
TW (1)	TWI276434B (de)
WO (1)	WO2000057867A2 (de)
ZA (1)	ZA200107736B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100366249C (zh)	2002-09-29	2008-02-06	天津帝士力投资控股集团有限公司	一种替莫唑胺控释给药***
CN1742723A (zh) *	2004-09-02	2006-03-08	天津倍方科技发展有限公司	含有替莫唑胺－8－羧酸酯的药物组合物以及该类化合物用于制备抗肿瘤药物的用途
CN1299772C (zh) *	2004-10-14	2007-02-14	孔庆忠	一种抗癌药物组合物
AU2005304672B2 (en) *	2004-11-09	2010-03-11	Schering Corporation	Improved dosing regimen of temozolomide for treating cancer based on the patient's MGMT level
EP2329818A1 (de) *	2006-01-17	2011-06-08	Abbott Laboratories	Kombinationstherapie mit PARP Inhibitoren
US7563801B2 (en) *	2006-04-05	2009-07-21	Schering Corporation	Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
AR061618A1 (es) *	2006-06-26	2008-09-10	Schering Corp	Formas de dosificacion unitaria de temozolomida
WO2008022535A1 (fr) *	2006-08-09	2008-02-28	Tian Jin Tasly Group Co., Ltd.	Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
NZ575636A (en) *	2006-09-29	2012-02-24	Cipla Ltd	An improved process for the preparation of temozolomide and analogs
US20140005160A1 (en) *	2010-12-01	2014-01-02	Hooshmand SHESHBARADARAN	Method for Treating Refractory Cancer
CN102526038B (zh) *	2011-01-12	2013-09-11	北京人福军威医药技术开发有限公司	替莫唑胺的脑靶向药物组合物及其应用
CN107397735B (zh) *	2017-07-28	2020-07-10	东曜药业有限公司	一种替莫唑胺药物组合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU719074B2 (en) *	1995-10-04	2000-05-04	Schering Corporation	Combination of temozolomide and alpha-IFN for the treatment of advanced cancer
CA2184545A1 (en) *	1996-07-31	1998-02-01	Pascale Reidenberg	Cancer treatment with temozolomide
CA2184546A1 (en) *	1996-07-31	1998-02-01	Margaret H. Dugan	Method for treating pediatric high grade astrocytoma including brain stem glioma

2000
- 2000-03-27 HU HU0200805A patent/HUP0200805A3/hu unknown
- 2000-03-27 NZ NZ536302A patent/NZ536302A/en unknown
- 2000-03-27 CN CN00805865A patent/CN1345240A/zh active Pending
- 2000-03-27 CA CA002368614A patent/CA2368614C/en not_active Expired - Fee Related
- 2000-03-27 WO PCT/US2000/008079 patent/WO2000057867A2/en active IP Right Grant
- 2000-03-27 DK DK00918435T patent/DK1165071T3/da active
- 2000-03-27 CN CN2011100359769A patent/CN102160864A/zh active Pending
- 2000-03-27 TW TW089105564A patent/TWI276434B/zh not_active IP Right Cessation
- 2000-03-27 JP JP2000607618A patent/JP2002540148A/ja active Pending
- 2000-03-27 AU AU39244/00A patent/AU780892B2/en not_active Ceased
- 2000-03-27 AT AT00918435T patent/ATE310515T1/de active
- 2000-03-27 DE DE60024243T patent/DE60024243T2/de not_active Expired - Lifetime
- 2000-03-27 ES ES00918435T patent/ES2251987T3/es not_active Expired - Lifetime
- 2000-03-27 AR ARP000101370A patent/AR023185A1/es unknown
- 2000-03-27 BR BR0009380-7A patent/BR0009380A/pt not_active Application Discontinuation
- 2000-03-27 EP EP00918435A patent/EP1165071B1/de not_active Expired - Lifetime
2001
- 2001-09-19 ZA ZA200107736A patent/ZA200107736B/xx unknown
- 2001-09-28 NO NO20014725A patent/NO330651B1/no not_active IP Right Cessation
2002
- 2002-05-02 HK HK02103318.7A patent/HK1044111B/zh not_active IP Right Cessation
2007
- 2007-03-20 JP JP2007073722A patent/JP2007169297A/ja active Pending

Also Published As

Publication number	Publication date
CA2368614A1 (en)	2000-10-05
EP1165071B1 (de)	2005-11-23
JP2002540148A (ja)	2002-11-26
CN102160864A (zh)	2011-08-24
HK1044111B (zh)	2006-02-24
EP1165071A2 (de)	2002-01-02
NZ536302A (en)	2006-05-26
HUP0200805A2 (hu)	2002-07-29
NO20014725D0 (no)	2001-09-28
BR0009380A (pt)	2001-12-26
WO2000057867A2 (en)	2000-10-05
AU780892B2 (en)	2005-04-21
CA2368614C (en)	2008-07-22
WO2000057867A3 (en)	2001-04-19
NO330651B1 (no)	2011-05-30
ES2251987T3 (es)	2006-05-16
DE60024243T2 (de)	2006-08-17
AR023185A1 (es)	2002-09-04
HUP0200805A3 (en)	2004-07-28
DK1165071T3 (da)	2006-02-20
DE60024243D1 (de)	2005-12-29
NO20014725L (no)	2001-11-13
ZA200107736B (en)	2003-02-26
JP2007169297A (ja)	2007-07-05
HK1044111A1 (en)	2002-10-11
TWI276434B (en)	2007-03-21
CN1345240A (zh)	2002-04-17
AU3924400A (en)	2000-10-16

Legal Events

Date

Code

Title

Description

2006-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1165071

Country of ref document: EP

Publication	Publication Date	Title
DK1637127T3 (da)	2014-08-04	Terapeutisk mikroskum
NO20021400L (no)	2002-05-06	Terapeutiske kinazolinderivater
DE60001530D1 (de)	2003-04-10	Verbinder
DE60006630D1 (de)	2003-12-24	Verbinder
DE60020922D1 (de)	2005-07-28	Verbinder
FI20000863A (fi)	2000-10-13	Uusi hoitomenetelmä
AR028476A1 (es)	2003-05-14	Tratamiento del cancer
DE60008069D1 (de)	2004-03-11	Verbinder
DE60019059D1 (de)	2005-05-04	Verbinder
DE60001032D1 (de)	2003-01-30	Verbinder
DE60017816D1 (de)	2005-03-10	Herzschrittmacher
DE60023454D1 (de)	2005-12-01	Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
NO20020358L (no)	2002-03-21	Anvendelse av etodolac til behandling av kreft
DE60015473D1 (de)	2004-12-09	Verbinder
DE60024243D1 (de)	2005-12-29	Verbesserte krebsbehandlung mit temozolomid
DE60001783D1 (de)	2003-04-30	Verbinder
DE60016600D1 (de)	2005-01-13	Herzschrittmacher
DE59911113D1 (de)	2004-12-23	Herzschrittmacher
DE60003993D1 (de)	2003-08-28	Verbinder
NO20013596L (no)	2001-08-20	Slambehandling
DE69916133D1 (de)	2004-05-06	Elektro-neuro-adaptiver stimulator
ATE302165T1 (de)	2005-09-15	Wasserbehandlung
DE60013608D1 (de)	2004-10-14	Herzschrittmacher
DE60017062D1 (de)	2005-02-03	Verbinder
DE60014496D1 (de)	2004-11-11	Verbinder